Civic AI
Procurement intelligence
Federal contract award
THE PURPOSE OF THIS MODIFICATION IS TO: 1. EXTEND THE BASE PERIOD, CLIN 0001, AT NO ADDITIONAL COST THROUGH 31 MAY 2026. 2. INCLUDE PROVISIONAL INDIRECT AND FRINGE RATES.
HOPO THERAPEUTICS, INC. · Department of Health and Human Services
- Value
- $14,209,253
- Start
- Sep 30, 2024
- End
- Dec 31, 2026
- Action date
- Apr 27, 2026
- PIID
- 75A50124C00062
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- BERKELEY, CA
- Award type
- DEFINITIVE CONTRACT
Description
THE PURPOSE OF THIS MODIFICATION IS TO: 1. EXTEND THE BASE PERIOD, CLIN 0001, AT NO ADDITIONAL COST THROUGH 31 MAY 2026. 2. INCLUDE PROVISIONAL INDIRECT AND FRINGE RATES.
Need modifications, related awards, and vendor peers? Open the full award workspace.